Circulating tumor cells and drug history in primary breast cancer patients
Open Access
- 1 January 2020
- journal article
- research article
- Published by OAE Publishing Inc. in Cancer Drug Resistance
- Vol. 3 (1), 98-109
- https://doi.org/10.20517/cdr.2019.79
Abstract
Cancer Drug Resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Both clinical and experimental aspects of drug resistance in cancer are included.Keywords
This publication has 31 references indexed in Scilit:
- Circulating tumour cells in non-metastatic breast cancer: a prospective studyThe Lancet Oncology, 2012
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohortBreast Cancer Research and Treatment, 2011
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2011
- Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort StudyBritish Journal of Cancer, 2010
- Metformin: A Therapeutic Opportunity in Breast CancerClinical Cancer Research, 2010
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast CancerJournal of Clinical Oncology, 2009
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 2008
- Adult Weight Change and Risk of Postmenopausal Breast CancerJama-Journal Of The American Medical Association, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2004